Samaniego, Edgar
Neurología
Neurología Intervencionista, Cuidados Críticos Neurológicos
- Social:
Información personal
Medico neurólogo con especialidad en Stroke (Ictus) y tratamiento endovascular de aneurismas cerebrales, malformaciones arteriovenosas, fistulas arteriovenosas, enfermedad carotidea y oclusión de vasos cerebrales. Especialista con certificación para trabajar en los Estados Unidos y en el Ecuador (SENESCYT). Mas de 10 anos de experiencia en el tratamiento de enfermedad cerebrovascular. Mas de 80 publicaciones en revistas internacionales y un libro sobre el tratamiento de enfermedad cerebrovascular (Acute Stroke Management in the Era of Thrombectomy).
Títulos
| Año | Especialidad | Lugar |
|---|---|---|
| 2012 | Cirugía Neurointervencionista | Baptist Cardiac & Vascular Institute |
| 2010 | Cuidados Críticos Neurológicos y Stroke | Universidad de Stanford |
| 2008 | Neurología | University of Wisconsin Madison |
| 2004 | Magister en Ciencias Microbiología Médica e Inmunología | University of Wisconsin Madison |
| 2000 | Medicina y Cirugía | Universidad Central del Ecuador |
Experiencia laboral
| Año | Departamento | Cargo | Lugar |
|---|---|---|---|
| 2017 - Actualidad | Stroke y Cirugía Neurointervencionista | Director | Iowa City Veteran Affairs Hospital |
| 2015 - Actualidad | Neurología, Neurocirugía y Radiología | Profesor asociado | Unversity of Iowa Hospital and Clinics. |
| 2012 - Actualidad | Neurología Intervencionista | Médico activo | Hospital Metropolitano |
| 2012 - 2015 | Radiología, Neurointervencionismo | Director | Hospital Eugenio Espejo |
Otros datos
Educación
Idiomas
| Año | Centro |
|---|---|
| 2017 | FELLOWSHIP: Stroke Net Research Fellowship. Mentor: Enrique Leira, MD. Iowa city, IA. |
| 2012 | FELLOWSHIP: Neurointerventional Surgery, Baptist Cardiac and Vascular Institute, Program Director: Italo Linfante MD. Miami, FL. |
| 2010 | FELLOWSHIP: Neurocritical Care, Stanford University, Program Director: Christine Wijman MD, PHD. Stanford, CA |
| 2009 | FELLOWSHIP: Vascular Neurology, Stanford University, Program Director: Gregory Albers MD. Stanford, CA. |
| 2008 | RESIDENCY, Department of Neurology, University of Wisconsin, Progam Director: Nicholas Stanek, MD, Madison, Wisconsin |
| 2005 | INTERSHIP, Medical College of Wisconsin. Milwaukee, Wisconsin |
| 2004 | MS, University of Wisconsin. Advisor: Miroslav Malkovsky MD., PHD. Madison, Wisconsin |
| 2000 | MD, Universidad Central del Ecuador. Quito, Ecuador |
| Idioma | Nivel |
|---|---|
| Español | Nativo |
| Inglés | Avanzado |
Libros publicados
Trabajo en Estados Unidos
Honores y premios
Certificaciones
Investigaciones
| Libro de Stroke: Link |
| Universidad de Iowa: Link |
| Magna Cum Laude with the second highest GPA, out of 239 graduates. Universidad Central del Ecuador: Septemtber of 2000 |
| General Secretariat Organization of American States, Leo S. Rowe Pan American Fund Scholarship to Study Molecular Microbiology: 2001 |
| Francis M. Foster Award for Best Presentation: “Inpatient and Community Ischemic Strokes in a University Hospital”. Wisconsin Neurological Society: 2006 |
| Medical Student Teaching Award, University of Wisconsin – Madison: 2008. |
| Recipient of an O1A visa from the Department of State of USA for individuals with extraordinary ability or achievement in sciences, specifically in the areas of Vascular Neurology and Neurocritical Care |
| American Academy of Neurology 2016 Diversity Leadership Program recipient |
| ECFMG (2002). PALS (2004). ACLS (2016). ATLS (2009) |
| American Board of Psychiatry and Neurology (2009 – 2019): Board in Neurology |
| United Council for Neurologic Subspecialties (2011): Board in Neurocritical Care |
| American Board of Psychiatry and Neurology (2011): Board in Vascular Neurology |
| Society of Neurological Surgeons Committee on Advanced Subspecialty Training (2017): NeuroEndovascular Surgery |
| 2017 | Drug-Eluting Stents for Endovascular Treatment of Ostial Vertebral Artery Stenosis. Iowa IRB: 201712811. Principal investigator |
| 2017 | Determination of Safety and Efficacy of Tirofiban in the Treatment of Cerebral Aneurysms. Iowa IRB: 201708751. Medicure research grant. Principal investigator |
| 2016 | NAVIGATE ESUS (Rivaroxaban versus Aspirin in secondary prevention of stroke and prevention of systemic embolism in patients with recent embolic stroke of undetermined source): NCT02313909. Clinical co-investigator. |
| 2016 | CREST 2 (Carotid Revascularization and Medical Management for Asysmptomatic Carotid Stenosis Trial): NCT02089217. Clinical co-investigator |
| 2016 | iDEF (Futility Study of Deferoxamine Mesylate in Intracerebral Hemorrhage): NCT02175225. Clinical co-investigator |
| 2016 | POINT (Platelet-Oriented Inhibition in New TIA): U01NS02683501A1. Clinical coinvestigator. |
| 2016 | SHINE (Stroke hyperglycemia insulin network effort trial): U01NS069498. Clinical coinvestigator. |
| 2016 | DEFUSE 3 (Endovascular therapy following imaging evaluation for ischemic stroke 3): U01NS092076. Clinical co-investigator |
| 2016 | Basilar Artery Stenosis Study. Iowa IRB: 201603762. Principal investigator |
| 2011 | TREVO (Thrombectomy Revascularization for Large Vessel Occlusions in Acute Ischemic Strokes): NCT01088672. Clinical co-investigator. |
| 2011 | VISSIT (Intracranial Stent Study for Ischemic Therapy): NCT00816166. Clinical coinvestigator. |
| 2010 | CLEAR-IVH (Clinical Trial on the Treatment of Intraventricular Hemorrhage): NCT 00650858. Clinical co-investigator. |
| 2009 | ALIAS trial (Albumin in Acute Ischemic Stroke Trial): NCT00235495. Clinical coinvestigator |
| 2008 | MISTIE (Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation): NCT00224770. Clinical co-investigator |
| 2006 | NeuroPace (Study of an External Responsive Neurostimulator System on Epileptiform Activity): NCT00158067. Clinical co-investigator |
| 2004 | Master of Science Thesis: “Activation of Gamma del T cells with Biphosphonates”. University of Wisconsin, Madison, Wisconsin (2004). |